# Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor

> **NCT01985256** · PHASE1 · COMPLETED · sponsor: **Tocagen Inc.** · enrollment: 17 (actual)

## Conditions studied

- Glioblastoma Multiforme
- Anaplastic Astrocytoma
- Anaplastic Oligodendroglioma
- Anaplastic Oligoastrocytoma

## Interventions

- **BIOLOGICAL:** Toca 511
- **DRUG:** Toca FC

## Key facts

- **NCT ID:** NCT01985256
- **Lead sponsor:** Tocagen Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2016-03-03
- **Final completion:** 2016-03-03
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2018-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01985256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01985256, "Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01985256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*